6 результати
TECHNICAL FIELD
The present disclosure consists of therapeutically-active compositions that combine strontium with at least one additional molecules that increase the overall therapeutic potency of the combination beyond the potency of any of the separate constituents. Specifically, the combinations
TECHNICAL FIELD
The present disclosure consists of therapeutically-active compositions that combine strontium with at least one additional molecules that increase the overall therapeutic potency of the combination beyond the potency of any of the separate constituents. Specifically, the combinations
TECHNICAL FIELD
The present disclosure consists of therapeutically-active compositions that combine strontium with at least one additional molecules that increase the overall therapeutic potency of the combination beyond the potency of any of the separate constituents. Specifically, the combinations
BACKGROUND
Strontium ranelate, a divalent strontium salt of ranelic acid, possesses a capacity to both stimulate bone formation and repress bone resorption. Strontium ranelate has been shown in clinical trials to protect against bone loss and to reduce fracture risk in postmenopausal women by both
FIELD OF THE INVENTION
This invention relates generally to compositions and methods useful in the prevention and treatment of osteoporosis and for bone and fracture repair. More specifically, the invention relates to slow-releasing calcium phosphate-based materials incorporating Mg, Zn, F, carbonate
The present invention relates to the use of alkaline-earth metal salts and more particularly of a strontium salt in a cosmetic, pharmaceutical, veterinary and/or dermatological composition as well as to the composition obtained. More particularly, these salts make it possible to treat, via the